Researchers observed that the lab - grown liver buds have molecular and genetic signature profiles that very closely resemble those found in naturally
developing human liver cells.
Not exact matches
In November 2010 Japanese researchers announced online in Analytical Chemistry that they had built a chip that simultaneously tests how
liver, intestine and breast cancer
cells respond to cancer drugs, and in February 2010 scientists publishing in the Proceedings of the National Academy of Sciences USA
developed a microscale replica of the
human liver that allowed them to observe the entire life cycle of hepatitis C, a virus that is difficult to observe in cultured
cells.
In this study, the Hiroshima University researchers
developed an animal model using severely immunodeficient mice whose
livers were partially populated with
human cells, in order to reconstruct elements of the
human immune system.
Rather than artificially triggering cancer by engineering genetic mutations, this model more closely mimics
human liver cancer in that tumors
develop as a natural consequence of non-alcoholic steatohepatitis (NASH), a chronic metabolic disorder that causes
liver damage, fibrosis and numerous
cell mutations.
«Our data give us a new, detailed understanding of the intercellular communication between
developing liver cells, and shows we can produce
human liver buds that come remarkably close to recapitulating fetal
cells from natural
human development.»
Generated from
human pluripotent stem
cells (hPSCs), the miniature organs are being
developed for their potential to study and treat
liver disease.
Characterization of
cells in the
developing human liver.
7/16/2008 Improved Culture System for Hepatitis C Virus Infection A University of California, San Diego School of Medicine researcher has
developed the first tissue culture of normal,
human liver cells that can model infection with the Hepatitis C virus (HCV) and provide a realistic environment to evaluate possible... More...
Researchers at the Wellcome Sanger Institute and Newcastle University have collected genomic data from over 250 thousand
cells from a range of donated
developing human tissues including
liver, skin, kidney and placenta.
The adult
livers of immunodeficient mice support
human hematopoiesis: evidence for a hepatic mast
cell population that
develops early in
human ontogeny.
San Diego, CA (March 31, 2009)-- Novocell, Inc., a stem
cell engineering company, today announced that it has received U.S. Patent 7,510,876 with claims covering
human definitive endoderm
cells, an essential
cell for generating not only pancreatic type
cells, which Novocell is
developing for use as a
cell therapy for diabetes, but also other endoderm lineage - derived tissues and organs such as lungs, intestine,
liver, thymus and thyroid.